Genus plc, together with its subsidiaries, engages in the application of quantitative genetics and biotechnology for animal breeding in the porcine and bovine sectors. It operates through three segments: Genus PIC, Genus ABS, and Research and Development. The company sells sows, boars, and semen under the PIC name to breed pigs with various characteristics for pork production. It also sells bull semen and embryos that are delivered through artificial insemination to breed diary and beef cattle with various characteristics for milk and beef production under the ABS name, as well as provides various in vitro fertilization services under the IVB name. The company serves pork, beef, and dairy farmers in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolLON:GNS
CUSIPN/A
Phone+44-1256-347100
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.44%
Return on Equity4.92%
Return on Assets2.69%
Miscellaneous
EmployeesN/A
Outstanding Shares61,530,000
Genus (LON:GNS) Frequently Asked Questions
What is Genus' stock symbol?
Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."
How often does Genus pay dividends? What is the dividend yield for Genus?
Genus announced a dividend on Wednesday, February 28th. Shareholders of record on Thursday, March 8th will be paid a dividend of GBX 8.10 per share on Wednesday, April 4th. This represents a yield of 0.37%. The ex-dividend date is Thursday, March 8th. The official announcement can be viewed at this link. View Genus' Dividend History.
What price target have analysts set for GNS?
6 Wall Street analysts have issued twelve-month target prices for Genus' shares. Their predictions range from GBX 1,800 to GBX 2,600. On average, they anticipate Genus' share price to reach GBX 2,242.17 in the next twelve months. View Analyst Ratings for Genus.
Who are some of Genus' key competitors?
Some companies that are related to Genus include ABLYNX NV/ADR (ABLX), MorphoSys (MPSYY), BTG (BTG), Abcam (ABC), MorphoSys (MOR), Sosei Group (SOLTF), Sirtex Medical (SRX), Biotest (BIO), ProMetic Life Sciences (PLI), Genfit (GNFTF), Mesoblast (MSB), Theratechnologies (TH), Mesoblast (MEOBF), Emerald Health Therapeutics (EMH) and Starpharma (SPL).
Who are Genus' key executives?
Genus' management team includes the folowing people:
- Mr. Karim Bitar, Chief Exec. Officer and Exec. Director (Age 53)
- Mr. Stephen Wilson, Group Fin. Director & Exec. Director (Age 58)
- Dr. Jonathan Lightner Ph.D., Chief of R&D and Scientific Officer
- Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
- Ms. Angelle R. Rosata SPHR, Group HR Director
Has Genus been receiving favorable news coverage?
News stories about GNS stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Genus earned a daily sentiment score of 0.14 on Accern's scale. They also assigned media stories about the company an impact score of 45.89 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Genus?
Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Genus' stock price today?
One share of GNS stock can currently be purchased for approximately GBX 2,542.
How big of a company is Genus?
Genus has a market capitalization of £1.43 billion.
How can I contact Genus?
Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.
MarketBeat Community Rating for Genus (GNS)
MarketBeat's community ratings are surveys of what our community members think about Genus and other stocks. Vote "Outperform" if you believe GNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
